Ovid Therapeutics Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Ovid Therapeutics Inc. (OVID) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$45.07 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-05-08
- Ovid Therapeutics Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-03-31 was -$45.07M.
- Ovid Therapeutics Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was $61.71K.
- Ovid Therapeutics Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was -$25.33K.
- Ovid Therapeutics Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$31.19K.
- Ovid Therapeutics Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$47.39K.
- Ovid Therapeutics Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$188.99K.
- Ovid Therapeutics Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$56.33K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2018-03-31 | -$45.07M 10-Q · filed 2018-05-08 | -$45.01M derived: sum of 2 quarters · filed 2018-05-08 | -$45.04M derived: sum of 3 quarters · filed 2018-05-08 | -$45.07M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-12-31 | $61.71K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $36.38K derived: sum of 2 quarters · filed 2018-03-29 | $5.18K derived: sum of 3 quarters · filed 2018-03-29 | -$47.39K 10-K · filed 2018-03-29 |
| 2017-09-30 | -$25.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$56.52K derived: sum of 2 quarters · filed 2017-11-09 | -$109.09K 10-Q · filed 2017-11-09 | -$197.19K derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-06-30 | -$31.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$83.76K 10-Q · filed 2017-08-10 | -$171.86K derived: sum of 3 quarters · filed 2018-05-08 | -$237.30K derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-03-31 | -$52.57K 10-Q · filed 2018-05-08 | -$140.66K derived: sum of 2 quarters · filed 2018-05-08 | -$206.11K derived: sum of 3 quarters · filed 2018-05-08 | -$213.40K derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | -$88.09K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | -$153.54K derived: sum of 2 quarters · filed 2018-03-29 | -$160.83K derived: sum of 3 quarters · filed 2018-03-29 | -$188.99K 10-K · filed 2018-03-29 |
| 2016-09-30 | -$65.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$72.74K derived: sum of 2 quarters · filed 2017-11-09 | -$100.89K 10-Q · filed 2017-11-09 | |
| 2016-06-30 | -$7.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$35.45K 10-Q · filed 2017-08-10 | ||
| 2016-03-31 | -$28.15K 10-Q · filed 2017-06-13 | |||
| 2015-12-31 | -$56.33K 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |